Last reviewed · How we verify

NCT04893824

Grappler® Interference Screw Post-Market Clinical Follow-Up Study

Completed Last updated 15 November 2023
What this trial tests

trial testing Grappler® Interference Screw System in Ankle Injuries in 50 participants. Completed in 25 March 2022.

Timeline
19 April 2021
Primary endpoint
11 March 2022
25 March 2022

Quick facts

Lead sponsorParagon 28
StatusCompleted
Study typeOBSERVATIONAL
Enrollment50
Start date19 April 2021
Primary completion11 March 2022
Estimated completion25 March 2022
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Paragon 28

Who can join

Eligibility, any sex, with Ankle Injuries or Syndesmotic Injuries. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Ambispective, multi-surgeon, single site, consecutive case series to determine the safety, performance, and benefits of the Grappler(R) Interference Screw.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Ankle Injuries

Currently open trials in the same condition.

Other Paragon 28 trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04893824.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing